OMICS Technologies For Predictive Modeling of Infectious Diseases Program

by:

The National Institute of Health, more commonly referred to as NIH, is a federal government agency operating within the United States Department of Health and Human Services that is primarily responsible for supporting the country's biomedical and health-related research studies.

The grants and initiatives of the NIH are all geared towards the successful realization of its primary agency mission which is to "seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the burdens of illness and disability."

In keeping with this mission, the National Institutes of Health has formed a partnership with the National Institute of Allergy and Infectious Diseases (NIAID) in an attempt to establish the OMICS Technologies For Predictive Modeling of Infectious Diseases Program.

The program is specifically designed to aid in the development and validation of predictive models of infectious disease initiation, progression and outcomes while employing integrated datasets generated from a combination of "omics" technologies.

OMICS technologies refer to the process involving rapid and accurate measurements tens and hundreds of thousands of data points (i.e., DNA sequences, gene expression levels) in a short period of time.

At present, there four major types of "omics" technologies that are being used to gather data, these include genomics, transcriptomics, proteomics, metabolomics.

  (continued...)

OMICS Technologies For Predictive Modeling of Infectious Diseases Program
  Page 2

About The Author

Michael Saunders is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs.

He also maintains Websites providing resources on environmental grants and grants for youth programs.




Additional Resources



category - Health Grants

Small Business Innovation Research Phase IIB Bridge Awards
In line with this mission, the NIH has recently constituted the Small Business Innovation Research Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics Toward Commercialization Program.


Research to Advance Vaccine Safety Program
The Centers for Disease Control and Prevention has partnered with the National Institutes of Health and as a result, has developed the Research to Advance Vaccine Safety Program, wherein it seeks to obtain a more thorough understanding vaccine safety.


Combating Autism Act Initiative: National Interdisciplinary Training Resource Center Program
In keeping with this mission, the Health Resources and Services Administration has recently announced the establishment of the Combating Autism Act Initiative: National Interdisciplinary Training Resource Center Program wherein it aims to solicit applications from eligible entities that seek to run and manage a National Interdisciplinary Training Resource Center.


Pilot Surveillance System for High Impact/Low Prevalence Congenital and Inherited Conditions Program
The Centers for Disease Control and Prevention has recently established the Pilot Surveillance System for High Impact/Low Prevalence Congenital and Inherited Conditions Program wherein it seeks to create and evaluate a surveillance system for congenital and inherited disease conditions.






Declara’s founder Ramona Pierson has recently raised a new $16 million for her company to further its global operations and build out a smarter team.




Not for Profit Jobs in Nebraska

  Executive Director Jobs
  Substance Abuse Jobs
  Program Director Jobs
  Executive Director Jobs
  Social Services Jobs



Federal Government Grant and Assistance Programs



Edited by: Michael Saunders

© 2008-2024 Copyright Michael Saunders